ASSESSING THE RELATIONSHIP BETWEEN HBA1C AND URINARY ALBUMIN FOR EARLY NEPHROPATHY IN TYPE 2 DIABETES

Main Article Content

Stuti Gupta
Avnish Kumar
Rishabh Kaushik
Shishir Pandey
Sonali Bandil
Anish kumar

Keywords

Glycosylated hemoglobin, HbA1c, Urinary Albumin, Nephropathy, Type 2 Diabetes Mellitus

Abstract

Background: Urinary albumin excretion is considered an early marker of renal impairment in diabetic patients. The presence of albumin in urine, even in small amounts, signifies a disruption in the glomerular filtration barrier, which may precede overt clinical nephropathy. Several studies have indicated a correlation between HbA1c levels and urinary albumin excretion. Despite these findings, the relationship between HbA1c and urinary albumin excretion is complex and may be influenced by various factors, including the duration of diabetes, age, hypertension, and dyslipidemia. Material & Methods: A total of 180 subjects were included in the study diagnosed with Type 2 Diabetes Mellitus according to American Diabetes Association (ADA) criteria. 3 The cases were further categorized based on their albumin-to-creatinine ratio (ACR): 60 patients with normo-albuminuria (ACR < 30 mg/dL) and 60 patients with microalbuminuria (ACR 30-299 mg/dL). Additionally, 60 healthy subjects served as controls. The collected blood samples were centrifuged at 3000 rpm for 5 minutes, and the separated plasma was stored for biochemical analysis. The urine albumin-to-creatinine ratio was measured using the immune-turbidometric method. Results: A clear trend of worsening biochemical parameters with the progression from normo-albuminuria to micro-albuminuria, emphasizing the importance of early detection and management of blood sugar levels to prevent renal complications was seen. Observations also indicates a significant correlations between urine albumin levels and various biochemical parameters in Type 2 Diabetes Mellitus patients. The strongest correlation with serum creatinine underscores the importance of monitoring renal function in these patients, while associations with fasting and postprandial blood sugar levels, as well as HbA1C, highlight the role of glycemic control in the prevention of kidney complications. Conclusion: This study demonstrates a significant relationship between HbA1c levels and urinary albumin excretion in patients with type 2 diabetes, suggesting that higher HbA1c may indicate an increased risk of nephropathy. Regular monitoring of both markers is essential for early detection of renal complications, enabling timely interventions to preserve kidney function.


 

Abstract 33 | pdf Downloads 10

References

1. International Diabetes Federation. (2021). IDF Diabetes Atlas (10th ed.). Brussels, Belgium: IDF.[ Last accessed on 30 Sept, 2024]
2. Bash, L. D., et al. (2021). Diabetic nephropathy: A review of the literature. Journal of Diabetes Research, 2021, 1-10.
3. American Diabetes Association. (2022). Standards of medical care in diabetes—2022. Diabetes Care, 45(Supplement 1), S1-S264.
4. K/DOQI. (2007). Clinical practice guidelines for nutrition in chronic kidney disease: 2000 update. American Journal of Kidney Diseases, 49(2), S1-S179.
5. Mora-Fernández, C., et al. (2014). Diabetic nephropathy: A complex and multifactorial disease. Clinical Kidney Journal, 7(1), 15-20.
6. Kahn, S. E., et al. (2016). Glycemic control and microalbuminuria in type 2 diabetes. Diabetes Care, 39(10), 1744-1750.
7. Wu, H., et al. (2020). Association between HbA1c levels and microalbuminuria in type 2 diabetes: A meta-analysis. Diabetes & Metabolism, 46(3), 205-212.
8. Eddy, A. A., & Neilson, E. G. (2006). Evolving concepts of diabetic nephropathy. Journal of the American Society of Nephrology, 17(1), 24-33.
9. Mora-Fernández, C., et al. (2014). Diabetic nephropathy: A complex and multifactorial disease. Clinical Kidney Journal, 7(1), 15-20.
10. Kahn, S. E., et al. (2016). Glycemic control and microalbuminuria in type 2 diabetes. Diabetes Care, 39(10), 1744-1750.
11. Eddy, A. A., & Neilson, E. G. (2006). Evolving concepts of diabetic nephropathy. Journal of the American Society of Nephrology, 17(1), 24-33.
12. Mora-Fernández, C., et al. (2014). Diabetic kidney disease: from physiology to therapeutics. Nature Reviews Nephrology, 10(10), 565-576. https://doi.org/10.1038/nrneph.2014.135
13. Friedman, A. N., et al. (2020). The effect of sodium-glucose cotransporter 2 inhibitors on renal outcomes in patients with diabetes: A systematic review and meta-analysis. Journal of Diabetes and its Complications, 34(4), 107554.
14. Ghosh, S., et al. (2015). The relationship between HbA1c and urinary albumin excretion in patients with type 2 diabetes. Indian Journal of Endocrinology and Metabolism, 19(5), 616-620.
15. Tanaka, S., et al. (2014). Relationship between HbA1c and urinary albumin excretion in Japanese patients with type 2 diabetes. Journal of Diabetes Investigation, 5(5), 578-583.
16. Chawla, A., et al. (2016). Association of HbA1c levels with diabetic nephropathy in type 2 diabetes. Journal of Clinical Endocrinology & Metabolism, 101(12), 4550-4557.
17. Perkins, B. A., et al. (2007). Urinary albumin excretion and HbA1c: a clinical perspective. Diabetes Research and Clinical Practice, 77(3), 382-388.
18. Perkins, B. A., et al. (2007). Urinary albumin excretion and HbA1c: a clinical perspective. Diabetes Research and Clinical Practice, 77(3), 382-388.
19. Shah, M. R., et al. (2016). The impact of HbA1c on nephropathy risk in diabetes. BMC Nephrology, 17(1), 1-8.
20. Sherwani, S. I., et al. (2016). Significance of HbA1c: a review of the literature. SAGE Open Medicine, 4, 1-9.
21. Van der Velde, M., et al. (2011). The relationship between HbA1c and renal function in type 2 diabetes. Nephrology Dialysis Transplantation, 26(5), 1676-1682.
22. Ghosh, S., & Mahapatra, S. (2017). The relationship between HbA1c and urinary albumin in diabetic nephropathy. Endocrine, 55(2), 481-487.
23. Jafar, T. H., et al. (2013). The relationship between HbA1c and kidney disease in diabetes. Clinical Journal of the American Society of Nephrology, 8(3), 479-487.
24. Kim, S. K., et al. (2015). Urinary albumin excretion and HbA1c levels in patients with type 2 diabetes. Diabetes Care, 38(10), 1825-1832.

Most read articles by the same author(s)